Founded in 2008 in Ankara, Doratek Medikal is a technology-driven company specializing in innovative implants for orthopedic, trauma, spinal, and craniofacial surgery. Since day one, our vision has been to strengthen the collaboration between surgeons and implants to create meaningful impact in healthcare. Clinical feedback, surgeons’ field experiences, and patient recovery processes are at the heart of our product development approach.

Product Portfolio and Technological Advantage

Doratek’s implant portfolio includes solutions for sports medicine (arthroscopic systems), spinal systems, craniofacial implants, hallux valgus plates, headless compression screws, and toe prostheses. All our products are CE certified and manufactured in compliance with the ISO 13485 quality management system, ensuring complete traceability from the supply chain to the operating room.

Advanced fixation systems such as the PressLock Knotless Anchor provide reliable fixation even in patients with low bone density, offering easy integration with traditional surgical techniques. These innovations are designed to reduce surgical time, minimize the need for revision surgeries, and enhance patient comfort.

Clinical Collaboration & R&D Process

Understanding clinical needs is the cornerstone of our innovation. We maintain close collaboration with surgeons, shaping prototypes based on their feedback from real surgical experiences. This approach enables us to address surgical challenges directly and develop solutions that enhance surgical workflow.

We focus on multiple parameters—fixation strategies, bone preservation, biomechanical optimization, and minimally invasive techniques—to ensure faster recovery, fewer complications, and higher surgeon satisfaction.

Growth Strategy: The Strength of Doratek Group with BMT Baps & BMT Calsis

Recently, under the Doratek Group umbrella, BMT Baps and BMT Calsis have joined our organization. These strategic acquisitions have expanded our portfolio to include cartilage repair, regenerative biomaterials, and bone filling solutions.

Within BMT Baps, cutting-edge cartilage regeneration technologies such as the ChondRoD Osteochondral Cartilage Implant are developed to address osteochondral defects.

Through BMT Calsis, we have added the Suprabone series of biomaterials to our portfolio — including Suprabone Putty, a β-TCP and hydrogel combination designed to enhance bone healing and available in both moldable and injectable forms.

With this integration, Doratek has evolved beyond an implant manufacturer to become a comprehensive technology ecosystem — uniting implants, biomaterials, and regenerative solutions under the Doratek Group.

Highlighted BMT Products & Applications

This expanded portfolio allows us to offer our customers a wide range of advanced products. Notable examples include:

• ChondRoD Osteochondral Cartilage Implant (BMT Baps): An innovative implant technology designed for the treatment of cartilage defects, promoting osteochondral tissue integration.


• Suprabone Putty (BMT Calsis): A β-TCP and hydrogel mixture available in moldable or injectable forms, supporting effective bone regeneration.


• Interference screws, suture anchors, and bone graft substitutes: A comprehensive range of products addressing traditional orthopedic needs.


Combined with Doratek’s implant solutions, these products create an integrated treatment scenario — covering not only bone fixation but also cartilage regeneration and biomaterial-assisted healing processes.

Education & Clinical Collaboration: The Expanding Role of Doratek Academy

Under the Doratek Academy, our training programs, workshops, cadaver labs, and clinical application sessions now include the new BMT solutions. Surgeons can receive hands-on training in both implant and biomaterial applications, while we gather valuable field feedback for continuous improvement.

These educational programs — with national and international participation — not only enhance knowledge sharing but also deepen engagement between users and our R&D teams, enabling faster product optimization.

Global Export & Strategic Vision

Today, Doratek Group exports to over 80 countries worldwide. With the addition of regenerative and biomaterial products, we have strengthened our international presence and addressed the growing global demand for cartilage repair and bone substitute solutions.

In the coming period, we aim to leverage our unified R&D infrastructure to focus on biotechnology, tissue engineering, and hybrid implant-biomaterial systems, positioning Doratek as an integrated medical technology group rather than solely an implant manufacturer.

Conclusion

With the inclusion of BMT Baps and BMT Calsis, Doratek Medikal now offers not only high-quality implant manufacturing but also a comprehensive range of biomaterial solutions, cartilage regeneration, and bone filling technologies.

This strategic integration enables us to meet surgeons’ needs with a broader spectrum of advanced and regenerative solutions — marking a new era for Doratek Group in the global medical technology landscape.